Pleurodesis success rate for malignant pleural effusions - talc slurry vs. poudrage

Khalis Boksh (Leicester, United Kingdom), Khalis Boksh, Charlotte Swales, Jonathan Bennett, Pranab Haldar, Muhammad Tufail, Rakesh Panchal

Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Session: Malignant pleural disease: diagnosis and management
Session type: Poster Discussion
Number: 3391
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Khalis Boksh (Leicester, United Kingdom), Khalis Boksh, Charlotte Swales, Jonathan Bennett, Pranab Haldar, Muhammad Tufail, Rakesh Panchal. Pleurodesis success rate for malignant pleural effusions - talc slurry vs. poudrage. Eur Respir J 2016; 48: Suppl. 60, 3391

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Outcomes of bedside talc slurry pleurodesis for malignant pleural effusions: A retrospective analysis
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Outcomes of the management of malignant pleural effusions with talc poudrage or talc slurry following medical thoracoscopy
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015


Thoracoscopic talc Poudrage pleurodesis for malignant effusions
Source: International Congress 2015 – Interventional pulmonology for pleural diseases
Year: 2015

Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE)
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016


Talc pleurodesis for malignant pleural effusion - effect on survival: Case-control follow-up study
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014


LATE-BREAKING ABSTRACT: Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


Efficacy of talc slurry pleurodesis in malignant pleural effusions
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


What outcome after pleurodesis in malignant pleural effusion in lung cancer?
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015


Prognostic factors associated to survival in patients with malignant pleural effusion (MPE) undergoing talc poudrage pleurodesis (TPP)
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Audit of success rate and complications of talc slurry pleurodesis for malignant pleural effusions
Source: Annual Congress 2008 - Pleural diseases and interventions
Year: 2008


Pleurodesis for malignant pleural effusions: A comparison of bleomycin or tranexamic acid alone versus a combination of both
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013

Predictive parameters of survival in malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Role of thoracoscopic pleural lavage and brush in undiagnosed exudative pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Lent score validation on patients with malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Iodopovidone pleurodesis in malignant pleural effusion: Is tube clamping time affected the efficacy & safety?
Source: Annual Congress 2013 –Chest wall and pleura
Year: 2013

Malignant pleural effusion (MPE) as debut of cancer
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015



Tunneled indwelling pleural catheter (TPC) in recurrent malignant pleural effusions: A retrospective study of 230 patients
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Therapeutic local procedures: pleurodesis
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=311
Year: 2002